ASP Isotopes Target of Unusually High Options Trading (NASDAQ:ASPI)

ASP Isotopes Inc. (NASDAQ:ASPI) saw unusually large options trading on Friday. Investors acquired 24,907 call options on the stock. This is an increase of 82% compared to the typical daily volume of 13,708 call options.

ASP Isotopes Stock Up 8.6%

NASDAQ:ASPI opened at $5.55 on Friday. ASP Isotopes has a 52 week low of $3.71 and a 52 week high of $14.49. The company has a quick ratio of 6.10, a current ratio of 6.14 and a debt-to-equity ratio of 1.04. The stock’s fifty day moving average is $6.22 and its two-hundred day moving average is $7.69. The stock has a market capitalization of $615.16 million, a price-to-earnings ratio of -4.27 and a beta of 3.55.

Analysts Set New Price Targets

A number of brokerages have recently commented on ASPI. Canaccord Genuity Group reaffirmed a “buy” rating and set a $11.00 price objective on shares of ASP Isotopes in a research note on Monday, November 24th. Cantor Fitzgerald started coverage on shares of ASP Isotopes in a report on Thursday, December 4th. They set an “overweight” rating and a $13.00 price target on the stock. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of ASP Isotopes in a research report on Monday, December 29th. Two equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $13.00.

Insider Transactions at ASP Isotopes

In related news, CEO Robert Ainscow sold 8,438 shares of ASP Isotopes stock in a transaction that occurred on Monday, December 8th. The stock was sold at an average price of $6.20, for a total transaction of $52,315.60. Following the completion of the transaction, the chief executive officer directly owned 1,546,255 shares in the company, valued at approximately $9,586,781. This trade represents a 0.54% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Heather Kiessling sold 80,000 shares of the business’s stock in a transaction that occurred on Thursday, December 18th. The shares were sold at an average price of $5.80, for a total value of $464,000.00. Following the completion of the transaction, the chief financial officer directly owned 732,500 shares of the company’s stock, valued at $4,248,500. The trade was a 9.85% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 14.40% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the stock. ProShare Advisors LLC grew its stake in shares of ASP Isotopes by 12.4% during the third quarter. ProShare Advisors LLC now owns 13,101 shares of the company’s stock worth $126,000 after purchasing an additional 1,448 shares in the last quarter. Ameritas Investment Partners Inc. boosted its holdings in ASP Isotopes by 41.2% in the second quarter. Ameritas Investment Partners Inc. now owns 5,483 shares of the company’s stock valued at $40,000 after purchasing an additional 1,600 shares in the last quarter. Mercer Global Advisors Inc. ADV increased its stake in ASP Isotopes by 8.3% in the third quarter. Mercer Global Advisors Inc. ADV now owns 21,056 shares of the company’s stock valued at $203,000 after purchasing an additional 1,622 shares during the last quarter. The Manufacturers Life Insurance Company boosted its holdings in shares of ASP Isotopes by 9.9% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 20,840 shares of the company’s stock valued at $153,000 after buying an additional 1,878 shares in the last quarter. Finally, Legal & General Group Plc raised its stake in ASP Isotopes by 30.4% during the 3rd quarter. Legal & General Group Plc now owns 8,377 shares of the company’s stock worth $81,000 after acquiring an additional 1,953 shares in the last quarter. 16.80% of the stock is currently owned by hedge funds and other institutional investors.

Key ASP Isotopes News

Here are the key news stories impacting ASP Isotopes this week:

• Positive Sentiment: QLE (ASPI subsidiary) signed a non‑binding MOU with a large U.S. energy company to evaluate support for establishing advanced nuclear fuel‑cycle facilities in the U.S., a strategic step that could attract partner funding or offtake support for ASPI’s domestic fuel‑supply plans. GlobeNewswire Release
• Positive Sentiment: Market coverage highlights the MOU as strengthening ASPI’s role in the U.S. nuclear fuel supply chain, bringing investor attention to potential long‑term contract opportunities and government/utility interest. Benzinga Article MSN Coverage
• Positive Sentiment: Unusually large call‑option activity: investors bought ~24,907 call options (an ~82% increase vs. average daily call volume), which signals short‑term bullish positioning from derivatives traders and can amplify upward stock moves.
• Positive Sentiment: QLE appointed Nate Salpeter, Ph.D., as CTO — an experienced technical hire that supports execution credibility for engineering and process development tied to ASPI’s fuel‑cycle ambitions. Business Insider: CTO Appointment
• Positive Sentiment: Investor visibility increased after ASPI interviews are scheduled to air on the RedChip “Small Stocks, Big Money” show on Bloomberg TV, which can boost retail attention and trading volume. Dispatch Press Release
• Neutral Sentiment: Short‑interest reports in recent feeds show zero shares or NaN changes (data appears inconsistent), so there’s no clear short‑position signal to explain the move; treat short‑interest figures as unreliable until exchanges provide corrected data.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.